Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985665 | SCV001134098 | uncertain significance | not provided | 2022-11-11 | criteria provided, single submitter | clinical testing | This frameshift variant alters the translational reading frame of the CDK4 mRNA and is predicted to cause the premature termination of CDK4 protein synthesis. The variant has not been reported in the published literature. It also has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). Based on the available information, we are unable to determine the clinical significance of this variant. |
Labcorp Genetics |
RCV001858625 | SCV002226261 | uncertain significance | Familial melanoma | 2022-07-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr294Leufs*4) in the CDK4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 10 amino acid(s) of the CDK4 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 801143). This variant has not been reported in the literature in individuals affected with CDK4-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). |